Mkts

Akebia Therapeutics, Inc.

NASDAQ: AKBA
$0.68+0.01 (+1.51%)
As of Oct 19, 4:00 PM ET

Key statistics

Day range
0.670.70
52-week range
0.673.20
Today
Open0.67
Previous close0.68
Volume—
Valuation
Market cap185.66M
P/E ratio—
EPS (TTM)-0.11
Income & risk
Dividend / yield—
Beta0.22
Avg volume6.52M
Discussion

AKBA News

Stories mentioning AKBA from around the web — every one is an open thread, so give it a like or add your take.

All news →

Loading news…

Financial statements

Financial statements

As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.

Line itemQ1 '26Mar 31Q4 '25Dec 31Q3 '25Sep 30Q2 '25Jun 30Q1 '25Mar 31Q4 '24Dec 31Q3 '24Sep 30Q2 '24Jun 30
Income Statement
Revenue53,54457,62258,76662,47257,33646,49737,42843,648
Cost of Goods Sold12,29012,5359,3839,9197,62520,36414,16117,047
Gross Profit41,25445,08749,38352,55349,71126,13323,26726,601
Operating Expenses
Research & Development14,80726,64814,94411,0139,75411,7878,4877,647
Sales General & Admin30,43626,08929,09426,55525,74227,67426,51626,917
Total Operating Expenses45,95053,64044,93438,46436,19740,43935,77235,326
Operating Income (Loss)(4,696)(8,553)4,44914,08913,514(14,306)(12,505)(8,725)
Interest Income
Interest Expense
Other Expense3.00(117.00)(10.00)(28.00)213.0055.00(17.00)(39.00)
Pretax Income(8,928)(11,235)1,155247.006,112(22,804)(20,039)(8,582)
Tax Provision126.00615.000.000.00
Net Income (Loss)(9,054)(12,244)540.00247.006,112(22,804)(20,039)(8,582)
Earnings Per Share (Basic)(0.03)(0.05)0.000.000.03(0.11)(0.10)(0.04)
Earnings Per Share (Diluted)(0.03)(0.05)0.000.000.03(0.11)(0.10)(0.04)
Weighted Average Shares Outstanding (Basic)267,047257,158264,786262,566235,498210,947210,348209,705
Weighted Average Shares Outstanding (Diluted)267,047257,158274,373271,104241,603210,947210,348209,705

Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.

Key facts

About AKBA

Akebia Therapeutics, Inc. (NASDAQ: AKBA) is a stock listed on the Nasdaq Stock Market under the ticker symbol AKBA. It last traded at $0.6800 (Oct 19, 2026, 4:00 PM ET), up 1.5% on the day. That gives Akebia Therapeutics a market capitalisation of $185.7M.

Over the past 52 weeks AKBA has traded between $0.6700 and $3.20.

Revenue for the quarter ended Mar 31, 2026 was $53.5M; a net loss of $9.1M. Revenue was down 6.6% from $57.3M in the quarter ended Mar 31, 2025.

Last 4 quarters
Quarter endedRevenueNet incomeMargin
Mar 31, 2026$53.5M-$9.1M-16.9%
Dec 31, 2025$57.6M-$12.2M-21.2%
Sep 30, 2025$58.8M$540.0K0.9%
Jun 30, 2025$62.5M$247.0K0.4%

From Akebia Therapeutics’s quarterly (10-Q) filings, in US dollars.

Latest News

Market news from around the web — every story is an open thread, so give it a like or add your take.

All news →

Loading news…